Diabetes | Fox Lake Towing and Recovery

Tag: diabetes

Pharmaceuticals Look Beyond Medications to Smartphone Apps

by Melly Alazraki on Feb.16, 2011, under Towing

Pharmaceutical companies looking for fresh sources of profit are increasingly investing in a range of health care innovations that aren’t drugs at all, from smartphone apps and educational websites to social media platforms and wireless devices, reports Ernst & Young.

Continue reading Pharmaceuticals Look Beyond Medications to Smartphone Apps

Pharmaceuticals Look Beyond Medications to Smartphone Apps originally appeared on DailyFinance on Wed, 16 Feb 2011 11:10:00.

Filed Under: Health Care, Pfizer, Qualcomm, Apple, Sanofi Aventis, Merck, GlaxoSmithKline, Novartis, Cisco Systems

Leave a Comment :@aoloriginal, AAPL, AAPL, PFE, MRK, SNY, NVS, GSK, QCOM, CSCO, MDT, Apple, cancer, Cisco Systems, CSCO, diabetes, drugs, Ernst Young, glaxosmithkline, GSK, Health Care, initiative, innovation, iphone, iphone app, MDT, medication, Merck, mobile health technology, MRK, Novartis, NVS, oncology, pfe, Pfizer, Pharma 3.0, pharmaceutical industry, pharmaceutical stocks, pharmaceuticals, QCOM, Qualcomm, sanofi-aventis, smart pill, smartphone, smartphone apps, SNY, treatment, weight loss, wireless devices more...

As Diabetes Explodes, Big Pharma Is Gearing Up

by Melly Alazraki on Jan.27, 2011, under Towing

Diabetes is a growing global scourge, but for Big Pharma it’s more of a lifesaver — and many drugmakers are cranking up their research efforts. After all, many existing drugs will soon be losing their patents, and diabetes could be a $55 billion market by 2019.

Continue reading As Diabetes Explodes, Big Pharma Is Gearing Up

As Diabetes Explodes, Big Pharma Is Gearing Up originally appeared on DailyFinance on Thu, 27 Jan 2011 18:00:00.

Filed Under: Investing, Health Care, Bristol-Myers Squibb, Sanofi Aventis, Merck, GlaxoSmithKline, Eli Lilly, Astrazeneca

Leave a Comment :@aoloriginal, AMLN, AstraZeneca, AZN, big pharma, BMY, Bristol-Myers Squibb, cdc, Centers for Disease Control and Prevention, diabetes, diabetes care, diabetes drug, diabetes drug stocks, drugmakers, Eli Lilly, glaxosmithkline, GSK, Health Care, insulin, Investing, LLY, Merck, MNKD, MRK, NVO, pharmaceutical stocks, pharmaceuticals, sanofi-aventis, SNY, type 1 diabetes, Type 2 diabetes, UNH, UNH, SNY, MRK, NVO, LLY, AMLN, GSK, BMY, AZN, MNKD more...

Abbott Laboratories Recalls 359 Million Diabetes Test Strips

by Danny King on Dec.22, 2010, under Towing

Abbott Laboratories is recalling roughly 359 million blood-sugar test strips for diabetics after the strips turned out to yield falsely low readings.

Continue reading Abbott Laboratories Recalls 359 Million Diabetes Test Strips

Abbott Laboratories Recalls 359 Million Diabetes Test Strips originally appeared on DailyFinance on Wed, 22 Dec 2010 19:15:00.

Filed Under: Company News, Technology, Health Care, Abbott

Leave a Comment :abbot labs, Abbott, Abbott Laboratories, abbott laboratories recall, Abbott Labs, abbott labs recall, Abbott recall, ABT, blood sugar, blood sugar balance, blood sugar control, blood sugar level, blood sugar levels, blood sugar regulation, blood sugars, Company News, diabetes, diabetes care, diabetic, diabetics, Health Care, medical, recall, recalled, Recalls, Technology more...

The CDC: Number of Americans With Diabetes Projected to Soar

by Michele Turk on Oct.31, 2010, under Towing

As many as one-third of American adults could develop diabetes in the next 40 years, according to a new analysis by the Centers for Disease Control and Prevention. The disease is also among the most expensive chronic illnesses to treat, and is considered one of the culprits in rising health care costs.

Continue reading The CDC: Number of Americans With Diabetes Projected to Soar

The CDC: Number of Americans With Diabetes Projected to Soar originally appeared on DailyFinance on Sun, 31 Oct 2010 11:00:00.

Filed Under: Health Care